🇸🇬 Country Profile

Singapore

Affordable medicine reaching Singapore

🇸🇬 $126M
All data from DGCIS India export records (fiscal year, April–March).
$126M
Scale
Singapore's healthcare system receives $126M in Indian pharmaceutical products each year, affordable, quality medicine.
54%
Medicine
A diverse pharmaceutical mix: medicines, medicine ingredients, and surgical & hospital supplies each contributing significantly.
1.4×
Trajectory
Steady growth over the decade: India's pharmaceutical supply to Singapore has expanded 1.4×.
Context
Part of India's pharmaceutical supply network across Asia-Pacific.
Impact
Indian pharmaceutical companies have both exported to and invested directly in Singapore, building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix, FY 2025–26 DGCIS
Medicines $67.5M (53.6%) Medicine Ingredients $47.7M (37.8%) Surgical & Hospital Supplies $6.0M (4.7%) Traditional & Herbal $2.8M (2.2%) Vaccines $2.0M (1.6%)
Top Products, FY 2025–26 DGCIS
Indian Pharma Investment in Singapore Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Singapore: $1.2B across 147 filings (2011-2026).